Оценка 4,0 · Groww HDFC Pharma And Healthcare Fund Direct Growth - Get latest NAV, SIP Returns & Rankings, Ratings, Fund Performance, Portfolio, Expense Ratio, ...

An open-ended equity scheme investing in Pharma and healthcare companies.

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies ...

Sectoral/Thematic :Sectoral/Thematic : The fund has 99.23% investment in domestic equities of which 39.79% is in Large Cap stocks, 11.49% is in Mid Cap stocks, ...

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare ...

Registered Address: I Think Techno Campus, Building, B, Alpha, Office Floor 8, Near Kanjurmarg Station, Kanjurmarg (East), Mumbai -400 042. Tel -022 30753400.

Learn about HDFC Pharma and Healthcare Fund Regular Growth with our data and independent analysis including NAV, star rating, portfolio, detailed portfolio, ...

It has an AUM of ₹1,382.60 Crores and the latest NAV decalared is ₹16.440 as on 25 Nov 2024 at 4:00 pm. HDFC Pharma And Healthcare Fund Direct - Growth scheme ...

HDFC Pharma And Healthcare Fund Direct - Growth returns of last 1-year are 52.40%. Since launch, it has delivered 54.17% average annual returns. The fund has ...

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare ...